ArticleBiology2022
Effects on Biomarkers in Stress Ecology Studies. Well, So What? What Now?
Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Effects assessed at higher levels of biological organization (populations and communities) are the consequence of the sum of effects on individuals, which usually result from impacts at cellular and molecular levels. Given this rationale, these lower levels of biological organization are more responsive at an early stage, making them potential resources that can be used as early warning endpoints to address environmental stress. In this way, the information concerning effects at the molecular level of biological organization (e.g., transcripts, proteins, or metabolites) allows for an early assessment of future ecosystem problems, which may eventually enable a timely intervention before the impacts become visible and irreversible. However, despite providing an early warning and a better understanding of the toxicity mechanisms, enabling the protection of biological integrity, the most significant setback is that these endpoints may fail to foresee later impacts on the environment due to the ecosystem resilience or a weak link to the effects in the following level of biological organization, making these tools simply too conservative for stakeholders' interests. Hence, an approach targeting lower levels of biological organization will greatly benefit from addressing potential effects at higher levels. This can be achieved by establishing a link in biological organization, where the effects assessed at the lower end of biological organization are linked with the high probability of causing an effect at the other end, inducing changes in populations and communities, and eventually altering ecosystems in the future.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.